<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7307834\results\search\disease\results.xml">
  <result pre="no modifications or adaptations are made. coronavirus COVID-19 ARS-CoV-2 severe" exact="acute" post="respiratory syndrome SARS-CoV Middle East respiratory syndrome MERS-CoV pandemic"/>
  <result pre="modifications or adaptations are made. coronavirus COVID-19 ARS-CoV-2 severe acute" exact="respiratory" post="syndrome SARS-CoV Middle East respiratory syndrome MERS-CoV pandemic lockdown"/>
  <result pre="or adaptations are made. coronavirus COVID-19 ARS-CoV-2 severe acute respiratory" exact="syndrome" post="SARS-CoV Middle East respiratory syndrome MERS-CoV pandemic lockdown immune"/>
  <result pre="coronavirus COVID-19 ARS-CoV-2 severe acute respiratory syndrome SARS-CoV Middle East" exact="respiratory" post="syndrome MERS-CoV pandemic lockdown immune system COVID-19 Since March,"/>
  <result pre="COVID-19 ARS-CoV-2 severe acute respiratory syndrome SARS-CoV Middle East respiratory" exact="syndrome" post="MERS-CoV pandemic lockdown immune system COVID-19 Since March, 2020,"/>
  <result pre="two decades, there have been at least three major coronavirus-based" exact="infectious disease" post="outbreaks/epidemics/pandemics: severe acute respiratory syndrome (SARS), 2002-2003; Middle East"/>
  <result pre="decades, there have been at least three major coronavirus-based infectious" exact="disease" post="outbreaks/epidemics/pandemics: severe acute respiratory syndrome (SARS), 2002-2003; Middle East"/>
  <result pre="been at least three major coronavirus-based infectious disease outbreaks/epidemics/pandemics: severe" exact="acute" post="respiratory syndrome (SARS), 2002-2003; Middle East respiratory syndrome (MERS),"/>
  <result pre="at least three major coronavirus-based infectious disease outbreaks/epidemics/pandemics: severe acute" exact="respiratory" post="syndrome (SARS), 2002-2003; Middle East respiratory syndrome (MERS), starting"/>
  <result pre="least three major coronavirus-based infectious disease outbreaks/epidemics/pandemics: severe acute respiratory" exact="syndrome" post="(SARS), 2002-2003; Middle East respiratory syndrome (MERS), starting in"/>
  <result pre="disease outbreaks/epidemics/pandemics: severe acute respiratory syndrome (SARS), 2002-2003; Middle East" exact="respiratory" post="syndrome (MERS), starting in 2012; COVID-19, starting in December"/>
  <result pre="outbreaks/epidemics/pandemics: severe acute respiratory syndrome (SARS), 2002-2003; Middle East respiratory" exact="syndrome" post="(MERS), starting in 2012; COVID-19, starting in December 2019."/>
  <result pre="number of biomarker, symptom, and other similarities among these three" exact="infectious diseases" post="(and influenza as well). For these infectious diseases, the"/>
  <result pre="these three infectious diseases (and influenza as well). For these" exact="infectious diseases," post="the members of the demographic affected most severely tend"/>
  <result pre="appears to be the main determinant of serious/fatal reaction to" exact="viral infection" post="(for COVID-19, SARS, and influenza alike). There are four"/>
  <result pre="to be the main determinant of serious/fatal reaction to viral" exact="infection" post="(for COVID-19, SARS, and influenza alike). There are four"/>
  <result pre="the immune system, in order to reduce adverse effects of" exact="viral" post="exposure. The three approaches that are mainly focused on"/>
  <result pre="facemasks, restricting large gatherings, etc. These measures will reduce the" exact="viral" post="load people will experience, and therefore reduce the levels"/>
  <result pre="stem cell transplantation patient recuperation, these measures will still allow" exact="viral" post="transmission and infection to occur. These measures do not"/>
  <result pre="patient recuperation, these measures will still allow viral transmission and" exact="infection" post="to occur. These measures do not strengthen the immune"/>
  <result pre="to require severe restrictions on the vast majority of the" exact="total" post="population when only required by a very small minority"/>
  <result pre="when only required by a very small minority of the" exact="total" post="population. Reactive/tactical treatments. Second are reactive/tactical measures to restrict"/>
  <result pre="population. Reactive/tactical treatments. Second are reactive/tactical measures to restrict the" exact="viral" post="load on the immune system, such that the immune"/>
  <result pre="experimenting with, treatments that were/are used to combat other mainly" exact="viral" post="diseases (15). As of 1 June, 2020, these treatments"/>
  <result pre="of 1 June, 2020, these treatments include, but are not" exact="limited" post="to: Actemra/Tocilizumab; Avigan/Favipiravir; Azithromycin; Baricitinib/Olumiant; Bevacizumab/Avastin; Calquence/Acalabrutinib; Chloroquine; Colcrys/Colchicine;"/>
  <result pre="of the most vulnerable. After such tactical treatments for one" exact="viral infection," post="people with weakened immune systems will again be vulnerable"/>
  <result pre="with weakened immune systems will again be vulnerable to serious" exact="infectious" post="consequences from exposure to the next harmful virus they"/>
  <result pre="unless they take active measures to strengthen their immune systems." exact="Local" post="treatments (aerosol, inhalers, nebulizers) may offer some benefit of"/>
  <result pre="some benefit of achieving ther-apeutic concentrations in affected tissues with" exact="lower" post="adverse effects (16). Vaccines. Third are the vaccines. Their"/>
  <result pre="see how true long-term safety can be validated within these" exact="limited" post="time scales. Numerous mid- and longer-term potential adverse effects"/>
  <result pre="(where vaccinated individuals may be at increased risk for other" exact="respiratory" post="viruses because they do not receive the non-specific immunity"/>
  <result pre="benefits of 'imprinting', a protection conferred upon children who experienced" exact="infection" post="at an early age) (22,23); iv) Non-specific vaccine effects"/>
  <result pre="(22,23); iv) Non-specific vaccine effects on immune system (where previous" exact="infections" post="can alter an individual's susceptibility to unrelated diseases) (24,25);"/>
  <result pre="on immune system (where previous infections can alter an individual's" exact="susceptibility to" post="unrelated diseases) (24,25); v) impact of infection route on"/>
  <result pre="an individual's susceptibility to unrelated diseases) (24,25); v) impact of" exact="infection" post="route on immune system (where immune protection can be"/>
  <result pre="aggregated) that contribute to weakening the immune system (29). The" exact="complete" post="study showing all the factors identified will be posted"/>
  <result pre="weaken the immune system include: Lifestyle (e.g., smoking, excess alcohol," exact="substance abuse," post="high-fat diet, protein-deficient diet, high-cholesterol diet, Western-style diets and"/>
  <result pre="abuse, high-fat diet, protein-deficient diet, high-cholesterol diet, Western-style diets and" exact="chronic" post="sleep restriction); Iatrogenic (e.g., immunosuppressive drugs, gamma radiation treatments,"/>
  <result pre="cyanobacteria, yessotoxin, scorpion venom; Streptomyces californicus; Pseudomonas aeruginosa; Rhinovirus and" exact="respiratory" post="syncytial virus); Occupational/Environmental (e.g., microplastics, endocrine-disrupting chemicals, heavy metals,"/>
  <result pre="wireless radiation-cell phones/cell towers/WiFi and sodium fluoride); PsychoSocial/SocioEconomic (e.g., depression," exact="chronic" post="stress, restraint stress, social isolation, stressful life events, and"/>
  <result pre="chronic stress, restraint stress, social isolation, stressful life events, and" exact="childhood" post="adversity). Eliminating/ameliorating these toxic exposures/behaviors will require a combination"/>
  <result pre="glutamine, arginine and branched-chain amino acids (BCAAs); high omega-3 versus" exact="lower" post="saturated, trans fat, and omega-6 fatty acids, low refined"/>
  <result pre="severe restrictions on activities of the vast majority of the" exact="total" post="population that are mainly applicable to the most vulnerable,"/>
  <result pre="applicable to the most vulnerable, very small minority of the" exact="total" post="population. Second, repurposed (mainly) antiviral treatments can only be"/>
  <result pre="(mainly) antiviral treatments can only be expected to have very" exact="limited" post="results in controlling SARS-CoV-2 viral load of the most"/>
  <result pre="be expected to have very limited results in controlling SARS-CoV-2" exact="viral" post="load of the most severely impacted, based on trials"/>
  <result pre="real protection against a future COVID-19 pandemic or any other" exact="viral" post="pandemic is the one that was demonstrated to work"/>
  <result pre="Speed (currently working to produce a vaccine in a record" exact="short" post="time period in the USA) to identify and eliminate"/>
  <result pre="al.Clinical and biochemical indexes from 2019-nCoV infected patients linked to" exact="viral" post="loads and lung injurySci China Life Sci63364374202010.1007/s11427-020-1643-832048163 3MoPXingYXiaoYDengLZhaoQWangHXiongYChengZGaoSLiangKet al.Clinical"/>
  <result pre="injurySci China Life Sci63364374202010.1007/s11427-020-1643-832048163 3MoPXingYXiaoYDengLZhaoQWangHXiongYChengZGaoSLiangKet al.Clinical characteristics of refractory COVID-19" exact="pneumonia" post="in Wuhan, ChinaClin Infect Dis3162020Epub ahead of print10.1093/cid/ciaa27032173725 4QianGQYangNBDingFMaAHYWangZYShenYFShiCWLianXChuJGChenLet"/>
  <result pre="ChinaClin Infect Dis3122020Epub ahead of print 6TianSHuNLouJChenKKangXXiangZChenHWangDLiuNLiuDet al.Characteristics of COVID-19" exact="infection" post="in BeijingJ Infect80401406202010.1016/j.jinf.2020.02.01832112886 7HanHMaQLiCLiuRZhaoLWangWZhangPLiuXGaoGLiuFet al.Profiling serum cytokines in COVID-19"/>
  <result pre="serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are" exact="disease" post="severity predictorsEmerg Microbes Infect911231130202010.1080/22221751.2020.177012932475230 8YunHSunZWuJTangAHuMXiangZLaboratory data analysis of novel"/>
  <result pre="perspectives and challenges (Review)Int J Mol Med463162020 18HuismanWMartinaBEERimmelzwaanGFGrutersRAOsterhausADMEVaccine-induced enhancement of" exact="viral" post="infectionsVaccine27505512200910.1016/j.vaccine.2008.10.08719022319 19TaylorAFooS-SBruzzoneRDinhLVKingNJCMahalingamSFc receptors in antibody-dependent enhancement of viral infectionsImmunol"/>
  <result pre="enhancement of viral infectionsVaccine27505512200910.1016/j.vaccine.2008.10.08719022319 19TaylorAFooS-SBruzzoneRDinhLVKingNJCMahalingamSFc receptors in antibody-dependent enhancement of" exact="viral" post="infectionsImmunol Rev268340364201510.1111/imr.1236726497532 20WolffGGInfluenza vaccination and respiratory virus interference among"/>
  <result pre="in antibody-dependent enhancement of viral infectionsImmunol Rev268340364201510.1111/imr.1236726497532 20WolffGGInfluenza vaccination and" exact="respiratory" post="virus interference among Department of Defense personnel during the"/>
  <result pre="personnel during the 2017-2018 influenza seasonVaccine38350354202010.1016/j.vaccine.2019.10.00531607599 21CowlingBJFangVJNishiuraHChanKHNgSIpDKChiuSSLeungGMPeirisJSIncreased risk of noninfluenza" exact="respiratory" post="virus infections associated with receipt of inactivated influenza vaccineClin"/>
  <result pre="the 2017-2018 influenza seasonVaccine38350354202010.1016/j.vaccine.2019.10.00531607599 21CowlingBJFangVJNishiuraHChanKHNgSIpDKChiuSSLeungGMPeirisJSIncreased risk of noninfluenza respiratory virus" exact="infections" post="associated with receipt of inactivated influenza vaccineClin Infect Dis5417781783201210.1093/cid/cis30722423139"/>
  <result pre="potential imprint-regulated effect of vaccine (I-REV)Euro Surveill241900585201910.2807/1560-7917.ES.2019.24.46.1900585 23KelvinAAZambonMInfluenza imprinting in" exact="childhood" post="and the influence on vaccine response later in lifeEuro"/>
  <result pre="in lifeEuro Surveill241900720201910.2807/1560-7917.ES.2019.24.48.1900720 24BennCSNeteaMGSelinLKAabyPA small jab - a big effect:" exact="Nonspecific" post="immunomodulation by vaccinesTrends Immunol34431439201310.1016/j.it.2013.04.00423680130 25RakebrandtNJollerNInfection history determines susceptibility to"/>
  <result pre="big effect: Nonspecific immunomodulation by vaccinesTrends Immunol34431439201310.1016/j.it.2013.04.00423680130 25RakebrandtNJollerNInfection history determines" exact="susceptibility to" post="unrelated diseasesBioEssays41e1800191201910.1002/bies.20180019131132173 26DemarsALisonAMachelartAVan VyveMPotembergGVanderwindenJMDe BolleXLetessonJJMurailleERoute of infection strongly impacts"/>
  <result pre="history determines susceptibility to unrelated diseasesBioEssays41e1800191201910.1002/bies.20180019131132173 26DemarsALisonAMachelartAVan VyveMPotembergGVanderwindenJMDe BolleXLetessonJJMurailleERoute of" exact="infection" post="strongly impacts the host-pathogen relationshipFront Immunol101589201910.3389/fimmu.2019.0158931354728 27PascualDWYangXWangHGoodwinZHoffmanCClappBAlternative strategies for"/>
  <result pre="reevaluate the correlation between long-term effects of anthropogenic pollutants on" exact="viral" post="epidemic/pandemic events and prevalenceFood Chem Toxicol141111418202010.1016/j.fct.2020.11141832437891 30IddirMBritoADingeoGFernandez Del CampoSSSamoudaHLa"/>
  <result pre="immune systemLupus15746752200610.1177/096120330607000117153845 40YangHSunYCaiRChenYGuBThe impact of dietary fiber and probiotics in" exact="infectious" post="diseasesMicrob Pathog140103931202010.1016/j.micpath.2019.10393131846741 41SaeedFNadeemMAhmedRSNadeemMTArshadMSUllahAStudying the impact of nutritional immunology underlying"/>
  <result pre="interventions to improve immunityAm J Lifestyle Med10152169201410.1177/155982761455777330202268 43SkalnyAVRinkLAjsuvakovaOPAschnerMGritsenkoVAAlekseenkoSISvistunovAAPetrakisDSpandidosDAAasethJet al.Zinc and" exact="respiratory" post="tract infections: Perspectives for COVID-19 (Review)Int J Mol Med4617262020"/>
 </snippets>
</snippetsTree>
